Silver Nanofunctionalized Stent After Radiofrequency Ablation Suppresses Tissue Hyperplasia and Bacterial Growth
Overview
Authors
Affiliations
Intraductal radiofrequency (RF) ablation combined with placement of a self-expandable metal stent (SEMS) for malignant biliary obstruction has risks such as stent- and heat-induced biliary sludge and restenosis. Here, we investigated the efficacy of a silver nanoparticles (AgNPs)-coated SEMS to inhibit tissue hyperplasia and bacterial growth caused by RF ablation with stent placement in the rabbit bile duct. The release behavior and antibacterial effects of AgNPs-coated SEMSs were evaluated. Then, SEMSs were successfully placed in all rabbits immediately after RF ablation. Ag ions were rapidly released at the beginning and then showed a gradual release behavior. The AgNPs-coated SEMS significantly inhibited bacterial activity compared to the uncoated SEMS ( < 0.05). Cholangiography and histological examination confirmed that the level of tissue hyperplasia was significantly lower in the AgNPs group than in the control group (all < 0.05). Immunohistochemistry analyses revealed that TUNEL-, HSP 70-, and α-SMA-positive areas were significantly lower in the AgNPs group than in the control group (all < 0.05). Intraductal RF ablation combined with nanofunctionalized stent placement represents a promising new approach for suppressing thermal damage as well as stent-induced tissue hyperplasia and bacterial growth.
Recent research progresses of bioengineered biliary stents.
Yan J, Ye Z, Wang X, Zhong D, Wang Z, Yan T Mater Today Bio. 2024; 29:101290.
PMID: 39444940 PMC: 11497374. DOI: 10.1016/j.mtbio.2024.101290.
Li Y, Yuan K, Deng C, Tang H, Wang J, Dai X Bioact Mater. 2024; 42:587-612.
PMID: 39314863 PMC: 11417150. DOI: 10.1016/j.bioactmat.2024.08.031.
Lee H, Won D, Park S, Park Y, Kim J, Han G Bioact Mater. 2024; 37:172-190.
PMID: 38549771 PMC: 10972844. DOI: 10.1016/j.bioactmat.2024.03.018.
Won D, Park Y, Zeng C, Ryu D, Kim J, Kang J Front Bioeng Biotechnol. 2023; 11:1244569.
PMID: 37744261 PMC: 10516293. DOI: 10.3389/fbioe.2023.1244569.
Radiofrequency ablation for pancreatobiliary disease: an updated review.
Canakis A, Sharaiha R Ann Gastroenterol. 2023; 36(5):497-503.
PMID: 37664225 PMC: 10433252. DOI: 10.20524/aog.2023.0828.